Literature DB >> 10064230

Maternal immunization.

W P Glezen1, M Alpers.   

Abstract

Maternal immunization can enhance passive immunity of infants to pathogens that cause life-threatening illnesses. In most instances, immunization during pregnancy will provide important protection for the woman as well as for her offspring. The tetanus toxoid and influenza vaccines are examples of vaccines that provide a double benefit. Other vaccines under evaluation include those for respiratory syncytial virus, pneumococci, group B streptococci, and Haemophilus influenzae type b. Although most IgG antibody crosses the placenta in the third trimester, the process is time-dependent, dictating that immunization should be accomplished ideally at least 6 weeks prior to delivery. IgG1 antibodies are transferred preferentially. Maternal immunization has not interfered with active immunization of the infant. Inactivated vaccines administered in the third trimester of pregnancy pose no known risk to the woman or to her fetus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10064230     DOI: 10.1086/515122

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Infection of newborn piglets with Bordetella pertussis: a new model for pertussis.

Authors:  S Elahi; R Brownlie; J Korzeniowski; R Buchanan; B O'Connor; M S Peppler; S A Halperin; S F Lee; L A Babiuk; V Gerdts
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 2.  Vaccines: all things considered.

Authors:  Ken S Rosenthal; Daniel H Zimmerman
Journal:  Clin Vaccine Immunol       Date:  2006-08

3.  Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.

Authors:  B R Brodeur; M Boyer; I Charlebois; J Hamel; F Couture; C R Rioux; D Martin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  Maternal immunization.

Authors:  Helen Y Chu; Janet A Englund
Journal:  Clin Infect Dis       Date:  2014-05-05       Impact factor: 9.079

Review 5.  Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance.

Authors:  Cilicia S do Nascimento; Nayara F B Dos Santos; Rita C C Ferreira; Carla R Taddei
Journal:  Braz J Microbiol       Date:  2019-08-20       Impact factor: 2.476

6.  Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants.

Authors:  Jacinta P Francis; Peter C Richmond; William S Pomat; Audrey Michael; Helen Keno; Suparat Phuanukoonnon; Jan B Nelson; Melissa Whinnen; Tatjana Heinrich; Wendy-Anne Smith; Susan L Prescott; Patrick G Holt; Peter M Siba; Deborah Lehmann; Anita H J van den Biggelaar
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

7.  Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.

Authors:  Denis Martin; Stéphane Rioux; Edith Gagnon; Martine Boyer; Josée Hamel; Nathalie Charland; Bernard R Brodeur
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.

Authors:  Masamitsu Kono; Muneki Hotomi; Susan K Hollingshead; David E Briles; Noboru Yamanaka
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

9.  Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.

Authors:  Julie-Anne Quinn; Flor M Munoz; Bernard Gonik; Lourdes Frau; Clare Cutland; Tamala Mallett-Moore; Aimee Kissou; Frederick Wittke; Manoj Das; Tony Nunes; Savia Pye; Wendy Watson; Ana-Maria Alguacil Ramos; Jose F Cordero; Wan-Ting Huang; Sonali Kochhar; Jim Buttery
Journal:  Vaccine       Date:  2016-10-13       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.